Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.4 USD | +0.06% | +0.16% | -3.27% |
11:46am | J&J: positive trial for Tremfya in ulcerative colitis | CF |
11:41am | Valneva Names New Chief Scientific Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.27% | 364B | |
+38.10% | 705B | |
+32.50% | 583B | |
+20.23% | 332B | |
+5.21% | 291B | |
+16.92% | 238B | |
-3.60% | 210B | |
+10.43% | 209B | |
+9.13% | 169B | |
-1.34% | 162B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson to Consolidate Business Segments Under UK Brand